MERCK $45.99

down -0.38


17/5/2013 06:17 PM  |  NYSE : MRK  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : 20% - MRK has underperformed the S&P 500 by 5%

Get Trend Analysis Icon Get Trend Analysis

ETF Alternatives sponsored by



People viewing MRK also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 12.3K +1.86%
BOMDF ALLIED HEALTHCARE GROUP 18.8K +1.27%
HRDND DC BRANDS INTERNATIONAL INC. N 2.6M +1.00%
TRAB THERABIOGEN 970.8K +1.00%
NRGXQ NEUROLOGIX 100.0K +0.82%

MRK Stock Analysis

  1. Amgen Chased By The Bubble

    Amgen really needs the pipeline to come through to support this valuation.
  2. The “Healthy” Play In Contract Research Organizations

    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane clinical trial and lab work. This outsourcing will be a big win for the contract research organizations.
Free Reports
  1. View the Portfolios of the Worlds Top Investors, FREE!

    Learn from Warren Buffett, George Soros and More!
  2. FREE Futures Trading Package

    The Great Free Give a Way To Serious Futures Traders! Valued at $390!
  3. Free Corn and Ethanol Report!

    Learn how you can take advantage of an ethanol-driven bull market in corn.
Marketplace
Trading Center